*** MEDIA ADVISORY*** Sen. Johnson to Lead Roundtable on COVID-19 Vaccine Efficacy and Safety

WASHINGTON – U.S. Sen. Ron Johnson (R-Wis.) will lead a roundtable discussion, COVID-19 Vaccines: What They Are, How They Work, and Possible Causes of Injuries, to shed light on the current state of knowledge surrounding the vaccine and the path forward. Medical experts and doctors who specialize in COVID-19 vaccine research and treatment will join Sen. Johnson at the roundtable.

A livestream of the event will be available.

WHAT:               Roundtable discussion about the COVID-19 vaccine


WHO:                 Senator Ron Johnson, medical experts and doctors specializing in COVID-19


WHEN:               December 7, 2022

                          12:00 PM ET


WHERE:            Russell Senate Office Building, Kennedy Caucus Room 325


RSVP:                 Please RSVP by Wednesday, December 7 at 8:00 AM CT with name, outlet, email and phone number to press@ronjohnson.senate.gov.


In addition to doctors and academicians, the Senator also invited the following federal health agency heads, the CEO’s of Pfizer and Moderna, and other individuals who have developed, promoted and led the response to COVID-19 vaccines:

  1. Dr. Rochelle P. Walensky, MD, MPH, Director of the Centers for Disease Control and Prevention
  2. Dr. Lawrence A. Tabak, DDS, Ph.D., Acting Director of the National Institutes of Health
  3. Dr. John R. Raymond Sr., MD, President and CEO of Medical College of Wisconsin
  4. Dr. Albert Bourla, DVM, Ph.D., Chairman and Chief Executive Officer of Pfizer
  5. Dr. U?ur ?ahin, MD, Chief Executive Officer of BioNTech
  6. Stéphane Bancel, MBA, Chief Executive Officer of Moderna Therapeutics
  7. Dr. Ashish K. Jha, MD, MPH, White House Coronavirus Response Coordinator
  8. Dr. Anthony S. Fauci, MD, Director of the National Institute of Allergy and Infectious Diseases and Chief Medical Advisor to the President
  9. Dr. Robert M. Califf, MD, MACC, Commissioner of the Food and Drug Administration
  10. Dr. Peter Marks, MD, Ph.D., Director of the Center for Biologics Evaluation and Research at the Food and Drug Administration
  11. Dr. Tom Shimabukuro, MD, MPH, MBA, Centers for Disease Control and Prevention COVID-19 Vaccine Task Force